References
- Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol 2006;22:583–8
- Gomez-Puyou A, Saavedra-Lira E, Becker I, et al. Using evolutionary changes to achieve species-specific inhibition of enzyme action – studies with triosephosphate isomerase. Chem Biol 1995;2:847–55
- Velanker SS, Ray SS, Gokhale RS, et al. Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure 1997;5:751–61
- Cortés-Figueroa AA, Pérez-Torres A, Salaiza N, et al. A monoclonal antibody that inhibits Trypanosoma cruzi growth in vitro and its reaction with intracellular triosephosphate isomerase. Parasitol Res 2008;102:635–43
- Maldonado E, Soriano-García M, Moreno A, et al. Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes. J Mol Biol 1998;283:193–203
- Waley SG. Refolding of triose phosphate isomerase. Biochem J 1973;135:165–72
- Zabori S, Rudolph R, Jaenicke R. Folding and association of triose phosphate isomerase from rabbit muscle. Z Naturforsch C 1980;35:999–1004
- Olivares-Illana V, Pérez-Montfort R, López-Calahorra F, et al. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochem 2006;45:2556–60
- Olivares-Illana V, Rodríguez-Romero A, Becker I, et al. Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. PLoS Neglected Trop Dis 2007;1:e01
- Cardinale D, Salo-Ahen OM, Ferrari S, et al. Homodimeric enzymes as drug targets. Curr Med Chem 2010;17:826–46
- Cerecetto H, González M. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds. Mini Rev Med Chem 2008;8:1355–83
- Benitez D, Cabrera M, Hernández P, et al. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies. J Med Chem 2011;54:3624–36
- Alvarez G, Aguirre-López B, Varela J, et al. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity. Eur J Med Chem 2010;45:5767–72
- Alvarez G, Aguirre-López B, Cabrera N, et al. 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition. J Enzyme Inhib Med Chem 2012preprint. doi: 10.3109/14756366.2012.700928 (Early Online: http://informahealthcare.com/toc/enz/0/0)
- Ostoa-Saloma P, Garza-Ramos G, Ramírez J, et al. Cloning, expression and purification of triosephosphate isomerase from Trypanosoma cruzi. Eur J Biochem 1997;244:700–5
- Borchert TV, Pratt K, Zeelen JP, et al. Overexpression of trypanosomal triosephosphate isomerase in Escherichia coli and characterization of a dimer interface mutant. Eur J Biochem 1993;211:703–10
- Kohl L, Callens M, Wierenga RK, et al. Triosephosphate isomerase of Leishmania mexicana mexicana. Cloning and characterization of the gene, overexpression in Escherichia coli and analysis of the protein. Eur J Biochem 1994;220:331–8
- García-Torres I, Cabrera N, Torres-Larios A, et al. Identification of amino acids that account for long-range interactions in two triosephosphate isomerases from pathogenic trypanosomes. PLoS ONE 2011;6:e18791
- Pace CN, Vajdos F, Fee L, et al. How to measure and predict the molar absorption coefficient of a protein. Protein Sci 1995;4:2411–23
- Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–91
- Téllez-Valencia A, Avila-Ríos S, Pérez-Montfort R, et al. Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi. Biochem Biophys Res Commun 2002;295:958–63
- Zomosa-Signoret V, Hernández-Alcántara G, Reyes-Vivas H, et al. Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers. Biochemistry 2003;42:3311–18